Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 5, 2015, Pages 601-603

  Oliver, Eric T ^a   Sterba, P M ^a   Saini, S S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

basophil; urticaria

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

ADULT; AGED; ARTICLE; BASOPHIL; CHRONIC SPONTANEOUS URTICARIA; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HISTAMINE RELEASE; HUMAN; ITCH AND HIVES SCORE; LEUKOCYTE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REMISSION; SKIN DISEASE ASSESSMENT; SKINDEX 29; URTICARIA; CHRONIC DISEASE; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; BASOPHILS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; URTICARIA; YOUNG ADULT;

EID: 84926351944     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12578     Document Type: Article

References (15)

1. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW,. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
2. Vonakis BM, Saini SS,. New concepts in chronic urticaria. Curr Opin Immunol 2008; 20: 709-716.
3. Rorsman H,. Basopenia in urticaria. Acta Allergol 1961; 16: 185-215.
4. Kern F, Lichtenstein LM,. Defective histamine release in chronic urticaria. J Clin Invest 1976; 57: 1369-1377.
5. Eckman JA, Hamilton RG, Saini SS,. Independent evaluation of a commercial test for "autoimmune" urticaria in normal and chronic urticaria subjects. J Invest Dermatol 2009; 129: 1584-1586.
6. Eckman JA, Hamilton RG, Gober LM, Sterba PM, Saini SS,. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-1963.
7. Baker R, Vasagar K, Ohameje N, Gober L, Chen SC, Sterba PM, et al. Basophil histamine release activity and disease severity in chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2008; 100: 244-249.
8. Grattan CE, Dawn G, Gibbs S, Francis DM,. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003; 33: 337-341.
9. Sperr WR, Agis H, Semper H, Valenta R, Susani M, Sperr M, et al. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. Int Arch Allergy Immunol 1997; 114: 68-73.
10. Zaidi AK, Saini SS, Macglashan DW Jr,. Regulation of syk kinase and FcRbeta expression in human basophils during treatment with omalizumab. J Allergy Clin Immunol 2010; 125: 902-908.
11. Vonakis BM, Vasagar K, Gibbons SP Jr, Gober L, Sterba PM, Chang H, et al. Basophil FcepsilonRI histamine release parallels expression of src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 2007; 119: 441-448.
12. Sohler A, Pfeiffer CC,. The absolute basophil count and blood histamine levels. J Orthomol Psychiat 1984; 13: 1-4.
13. Sabroe RA, Greaves MW,. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 2006; 154: 813-819.
14. Luquin E, Kaplan AP, Ferrer M,. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005; 35: 456-460.
15. Greaves MW, Plummer VM, McLaughlan P, Stanworth DR,. Serum and cell bound IgE in chronic urticaria. Clin Allergy 1974; 4: 265-271.